Legend Biotech (LEGN) Other Working Capital Changes (2020 - 2025)

Legend Biotech (LEGN) has reported Other Working Capital Changes for 6 consecutive years, with $1.3 million the latest figure, recorded in Q3 2025.

• Quarterly Other Working Capital Changes rose 6.12% year-over-year to $1.3 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $2.5 million (up 2772.83% YoY) and the FY2022 annual result came in at -$163000.0, down 3.16% from the prior year.
• Other Working Capital Changes retreated to $1.3 million in Q3 2025 per LEGN's latest filing, from $9.0 million in the prior quarter.
• Over the last five years, Other Working Capital Changes for LEGN reached as high as $12.2 million in Q1 2023 and fell as low as -$50.6 million in Q4 2022.
• A 5-year average of -$15.4 million and a median of -$12.9 million in 2023 frame the typical range for Other Working Capital Changes.
• The largest YoY upside for Other Working Capital Changes was 242600.0% in 2024 against a maximum downside of 135244.44% in 2024.
• Year by year, Other Working Capital Changes stood at -$158000.0 in 2021, then fell by 3.16% to -$163000.0 in 2022, then tumbled by 653.99% to -$1.2 million in 2023, then soared by 197.07% to $1.2 million in 2024, then gained by 6.12% to $1.3 million in 2025.
• According to Business Quant data, Other Working Capital Changes over the past three periods registered $1.3 million, $9.0 million, and -$9.0 million for Q3 2025, Q2 2025, and Q1 2025 respectively.